M Tanaka

824 total citations
23 papers, 689 citations indexed

About

M Tanaka is a scholar working on Molecular Biology, Molecular Medicine and Pharmacology. According to data from OpenAlex, M Tanaka has authored 23 papers receiving a total of 689 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 6 papers in Molecular Medicine and 5 papers in Pharmacology. Recurrent topics in M Tanaka's work include Cancer therapeutics and mechanisms (7 papers), Antibiotic Resistance in Bacteria (6 papers) and Antibiotics Pharmacokinetics and Efficacy (5 papers). M Tanaka is often cited by papers focused on Cancer therapeutics and mechanisms (7 papers), Antibiotic Resistance in Bacteria (6 papers) and Antibiotics Pharmacokinetics and Efficacy (5 papers). M Tanaka collaborates with scholars based in Japan, China and United States. M Tanaka's co-authors include I Hayakawa, Y Osada, Kenichi Sato, Katsumasa Sato, Kazuki Hoshino, Yutaka Matsuura, M Kashimura, Naoyuki Toki, Toshinori Kawagoe and Yoshikuni Onodera and has published in prestigious journals such as Journal of Biological Chemistry, The Journal of Immunology and Antimicrobial Agents and Chemotherapy.

In The Last Decade

M Tanaka

22 papers receiving 651 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M Tanaka Japan 13 228 200 188 186 115 23 689
K.R. Marotti United States 17 602 2.6× 117 0.6× 146 0.8× 105 0.6× 308 2.7× 30 1.3k
G. H. Hottendorf United States 18 175 0.8× 284 1.4× 62 0.3× 71 0.4× 36 0.3× 44 819
Jane M. Knisely United States 9 342 1.5× 74 0.4× 129 0.7× 127 0.7× 48 0.4× 12 920
E van Strijen Netherlands 13 157 0.7× 133 0.7× 113 0.6× 132 0.7× 12 0.1× 17 579
Marije Buitelaar Netherlands 10 394 1.7× 115 0.6× 61 0.3× 27 0.1× 112 1.0× 11 1.2k
Tomoyuki Homma Japan 12 269 1.2× 100 0.5× 86 0.5× 56 0.3× 24 0.2× 24 690
T G Laffler United States 15 600 2.6× 36 0.2× 187 1.0× 39 0.2× 29 0.3× 28 1.0k
R Maller Sweden 14 91 0.4× 308 1.5× 173 0.9× 191 1.0× 28 0.2× 28 635
Mohammad Faheem Pakistan 13 160 0.7× 62 0.3× 97 0.5× 132 0.7× 62 0.5× 50 476

Countries citing papers authored by M Tanaka

Since Specialization
Citations

This map shows the geographic impact of M Tanaka's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M Tanaka with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M Tanaka more than expected).

Fields of papers citing papers by M Tanaka

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M Tanaka. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M Tanaka. The network helps show where M Tanaka may publish in the future.

Co-authorship network of co-authors of M Tanaka

This figure shows the co-authorship network connecting the top 25 collaborators of M Tanaka. A scholar is included among the top collaborators of M Tanaka based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M Tanaka. M Tanaka is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Matsuura, Yutaka, Toshinori Kawagoe, Naoyuki Toki, M Tanaka, & M Kashimura. (2006). Long-standing complications after treatment for cancer of the uterine cervix-clinical significance of medical examination at 5 years after treatment. International Journal of Gynecological Cancer. 16(1). 294–297. 80 indexed citations
2.
Lü, Xiaoxia, Shinya Yamamoto, M Tanaka, Tadaaki Hibi, & S. Namba. (1998). The genome organization of the broad bean necrosis virus (BBNV). Archives of Virology. 143(7). 1335–1348. 11 indexed citations
3.
Sahashi, Ko, et al.. (1997). [A mitochondrial DNA mutation in the heteroplasmic tRNA-Tyr gene associated with chronic progressive external ophthalmoplegia--clinical and molecular biological study].. PubMed. 55(12). 3265–9. 4 indexed citations
4.
Tanaka, M, et al.. (1997). Antimicrobial activity of DU-6681a, a parent compound of novel oral carbapenem DZ-2640. Antimicrobial Agents and Chemotherapy. 41(6). 1260–1268. 17 indexed citations
5.
Tanaka, M, et al.. (1997). Inhibitory activities of quinolones against DNA gyrase and topoisomerase IV purified from Staphylococcus aureus. Antimicrobial Agents and Chemotherapy. 41(11). 2362–2366. 65 indexed citations
6.
Tanaka, M, et al.. (1996). Mitochondrial DNA mutations associated with the 11778 mutation in Leber's disease.. PubMed. 38(4). 693–700. 6 indexed citations
7.
Tanaka, M, et al.. (1995). Mechanisms of 4-quinolone resistance in quinolone-resistant and methicillin-resistant Staphylococcus aureus isolates from Japan and China. Journal of Medical Microbiology. 42(3). 214–219. 28 indexed citations
8.
Inagaki, Yutaka, et al.. (1995). The effect of DU-6859a, a new potent fluoroquinolone, on fecal microflora in human volunteers.. PubMed. 48(3). 368–79. 7 indexed citations
9.
Nakajima, R, et al.. (1995). In vitro and in vivo antifungal activities of DU-6859a, a fluoroquinolone, in combination with amphotericin B and fluconazole against pathogenic fungi. Antimicrobial Agents and Chemotherapy. 39(7). 1517–1521. 50 indexed citations
10.
Nakashima, M, Toshihiko Uematsu, Kazuhiro Kosuge, et al.. (1995). Pharmacokinetics and tolerance of DU-6859a, a new fluoroquinolone, after single and multiple oral doses in healthy volunteers. Antimicrobial Agents and Chemotherapy. 39(1). 170–174. 64 indexed citations
11.
Tanaka, M, Hisato Jingami, Haruhisa Otani, et al.. (1993). Regulation of apolipoprotein B production and secretion in response to the change of intracellular cholesteryl ester contents in rabbit hepatocytes. Journal of Biological Chemistry. 268(17). 12713–12718. 96 indexed citations
12.
Tanaka, M, Kazuki Hoshino, Hiroko Ishida, et al.. (1993). Antimicrobial activity of DV-7751a, a new fluoroquinolone. Antimicrobial Agents and Chemotherapy. 37(10). 2112–2118. 15 indexed citations
13.
Sato, Katsumasa, Kazuki Hoshino, M Tanaka, I Hayakawa, & Y Osada. (1992). Antimicrobial activity of DU-6859, a new potent fluoroquinolone, against clinical isolates. Antimicrobial Agents and Chemotherapy. 36(7). 1491–1498. 108 indexed citations
14.
Tanaka, M, Kenichi Sato, Yasuharu Kimura, et al.. (1991). Inhibition by quinolones of DNA gyrase from Staphylococcus aureus. Antimicrobial Agents and Chemotherapy. 35(7). 1489–1491. 39 indexed citations
15.
Nambu, Mitsuhiko, Masao Morita, Hiroyuki Watanabe, et al.. (1989). Regulation of Fc gamma receptor expression and phagocytosis of a human monoblast cell line U937. Participation of cAMP and protein kinase C in the effects of IFN-gamma and phorbol ester.. The Journal of Immunology. 143(12). 4158–4165. 41 indexed citations
16.
Tanaka, M, et al.. (1988). Effect of Cyclosporin A on rat thymus: time course analysis by immunoperoxidase technique and flow cytofluorometry.. PubMed. 72(2). 216–21. 17 indexed citations
17.
Yoshimura, Teizo, et al.. (1987). Colony‐stimulating factor and leukemia cell‐growth factor produced by a murine endothelial cell line, MKM‐O. European Journal Of Haematology. 39(2). 136–143.
18.
Tanaka, M, et al.. (1987). Regulation of IgE receptor expression on human peripheral blood lymphocytes by lymphocytosis promoting factor (LPF), lectins and dexamethasone.. PubMed. 68(2). 418–26. 9 indexed citations
19.
Tanaka, M. (1970). [Immunological study of Bacteroides melaninogenicus].. PubMed. 70(12). 1508–19. 1 indexed citations
20.
Mitani, Yoshitsugu, Shintaro Takaki, Satoru Yamaguchi, et al.. (1956). Development of cervical cancer in surgical cases; surgical pathology of cervical cancer.. PubMed. 3(4). 324–41. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by K.R. Marotti Breakdown of academic impact, for papers by G. H. Hottendorf Breakdown of academic impact, for papers by Jane M. Knisely Breakdown of academic impact, for papers by E van Strijen Breakdown of academic impact, for papers by Marije Buitelaar Breakdown of academic impact, for papers by Tomoyuki Homma Breakdown of academic impact, for papers by T G Laffler Breakdown of academic impact, for papers by R Maller Breakdown of academic impact, for papers by Mohammad Faheem
Rankless by CCL
2026